Antibiotic resistance has become a major challenge in the treatment of serious bacterial infections. Some bacteria produce enzymes called beta-lactamases, which can break down certain beta-lactam antibiotics and make them less effective.
Avibactam injection is important in this area because avibactam is a non-beta-lactam beta-lactamase inhibitor. It can protect selected beta-lactam antibiotics from degradation by certain beta-lactamase enzymes. As a result, it is used in combination with specific antibiotics rather than as a standalone antibacterial treatment.
This article explains what avibactam injection is, how it works, where it is used, and why avibactam-based combinations are relevant to antimicrobial resistance.
What Is Avibactam Injection?
Avibactam is a beta-lactamase inhibitor developed to help protect partner beta-lactam antibiotics from certain resistance enzymes.
Avibactam itself is not generally used as an antibiotic alone. Instead, it is combined with an appropriate antibacterial agent. One of the best-known combinations is ceftazidime-avibactam, which combines avibactam with the cephalosporin antibiotic ceftazidime.
The purpose of this combination is straightforward:
Ceftazidime attacks susceptible bacteria, while avibactam helps protect ceftazidime from certain beta-lactamases.
This makes avibactam an important component of modern strategies for managing infections caused by some resistant Gram-negative bacteria.
How Does Avibactam Work?
Some bacteria develop resistance by producing beta-lactamase enzymes. These enzymes can hydrolyze the beta-lactam ring found in many antibiotics.
Avibactam works by binding to and inhibiting several clinically important beta-lactamases. This includes many Class A and Class C enzymes and some Class D enzymes.
By inhibiting susceptible beta-lactamases, avibactam can reduce enzymatic destruction of its partner antibiotic.
The overall concept can be summarized as:
Beta-lactam antibiotic + Avibactam → protection from susceptible beta-lactamases → improved antibacterial activity
However, avibactam does not inhibit every resistance mechanism. This is why microbiological testing, local resistance patterns, and appropriate clinical judgment remain important.
Avibactam Injection Uses
The most important clinical uses of avibactam are associated with combination therapies.
1. Ceftazidime-Avibactam
Ceftazidime-avibactam is one of the most established avibactam-containing combinations.
It may be used for selected serious infections caused by susceptible Gram-negative bacteria, including certain infections involving the:
- Urinary tract
- Intra-abdominal region
- Lungs
- Bloodstream
- Other sites depending on the approved indication and clinical circumstances
Ceftazidime-avibactam is particularly relevant when infections involve bacteria producing certain beta-lactamases.
2. Aztreonam-Avibactam
Another important combination is aztreonam-avibactam.
This combination is particularly interesting in the context of difficult-to-treat Gram-negative infections because aztreonam has activity against certain bacteria while remaining stable against metallo-beta-lactamases. Avibactam can inhibit other beta-lactamases that may otherwise compromise aztreonam activity.
The combination therefore represents an important approach to addressing complex resistance mechanisms.
Read more: Avibactam and Aztreonam Combination
Why Is Avibactam Important in Antibiotic Resistance?
Antimicrobial resistance can occur through several mechanisms, including changes in antibiotic targets, reduced drug entry, active drug efflux, and production of drug-inactivating enzymes.
Beta-lactamases are especially important because they can directly destroy many beta-lactam antibiotics.
Avibactam provides one strategy for overcoming specific beta-lactamase-mediated resistance.
However, it is important to understand that avibactam is not a universal resistance blocker. Some enzymes, especially metallo-beta-lactamases, are not inhibited by avibactam.
This distinction is clinically important because the resistance mechanism involved can influence whether an avibactam-containing combination is appropriate.
Avibactam and Resistant Gram-Negative Bacteria
Gram-negative bacteria can cause serious infections, particularly in hospitalized or vulnerable patients. Organisms such as Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and other Enterobacterales may develop resistance to multiple antibiotic classes.
Some resistant organisms produce enzymes such as:
- Extended-spectrum beta-lactamases (ESBLs)
- AmpC beta-lactamases
- KPC-type carbapenemases
- Certain OXA-type beta-lactamases
The activity of avibactam varies according to the enzyme involved. Therefore, the presence of a resistance gene alone does not automatically determine treatment choice.
Avibactam Injection and Ceftazidime Avibactam
The combination of ceftazidime and avibactam is especially relevant to the Aionios Pharma product portfolio.
Aionios Pharma’s Zamnios is a ceftazidime-avibactam product. For product-specific information, composition, approved indications, and prescribing details, readers should always refer to the official product information and qualified healthcare professionals.
Explore: Zamnios – Ceftazidime Avibactam
Is Avibactam an Antibiotic?
No. Avibactam is a beta-lactamase inhibitor, not a conventional antibiotic.
Its role is to inhibit certain beta-lactamases and help protect a partner beta-lactam antibiotic.
This distinction is important because avibactam is generally considered part of a combination antibacterial strategy rather than an independent antibacterial agent.
Avibactam Injection: Key Points
Here are the main points to remember:
- Avibactam is a non-beta-lactam beta-lactamase inhibitor.
- It is used with selected beta-lactam antibiotics.
- Ceftazidime-avibactam is a major avibactam-containing combination.
- Aztreonam-avibactam is another important combination in antimicrobial resistance management.
- Avibactam inhibits several clinically relevant beta-lactamases but not all resistance enzymes.
- Treatment decisions depend on the infecting organism, susceptibility results, infection site, patient factors, and applicable clinical guidelines.
- Avibactam-containing medicines should be used under appropriate medical supervision.
Frequently Asked Questions
What is avibactam injection used for?
Avibactam is used as part of combination antibiotic therapy to inhibit certain beta-lactamases and help protect its partner antibiotic from enzymatic degradation.
Is avibactam an antibiotic?
No. Avibactam is a beta-lactamase inhibitor. It is combined with selected antibiotics such as ceftazidime or aztreonam.
What is the most common avibactam combination?
One of the best-known combinations is ceftazidime-avibactam. Aztreonam-avibactam is another important combination used in the context of resistant Gram-negative infections.
Does avibactam work against all beta-lactamases?
No. Avibactam inhibits several important beta-lactamases, but it does not inhibit every type. Metallo-beta-lactamases, for example, are not inhibited by avibactam.
Can avibactam be used alone?
Avibactam is not generally used as a standalone antibacterial treatment. Its clinical role is to inhibit susceptible beta-lactamases and support the activity of a partner antibiotic.
Final Takeaway
Avibactam injection represents an important component of combination therapy for selected resistant bacterial infections. By inhibiting specific beta-lactamases, avibactam can help preserve the activity of partner antibiotics such as ceftazidime and aztreonam.
As antimicrobial resistance continues to evolve, understanding the mechanism, spectrum, and limitations of beta-lactamase inhibitors is increasingly important. The choice of an avibactam-containing therapy should always be based on the identified pathogen, susceptibility data, clinical guidelines, and professional medical judgment.